Use of C-type natriuretic peptide variants to treat osteoarthritis
US-11202819-B2 · Dec 21, 2021 · US
Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/58 |
| Official title | Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin |
| Display label | Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin |
| Total patents | 94 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 12 |
| 2016 | 11 |
| 2017 | 9 |
| 2018 | 11 |
| 2019 | 8 |
| 2020 | 3 |
| 2021 | 10 |
| 2022 | 10 |
| 2023 | 3 |
| 2024 | 8 |
| 2025 | 9 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
MANP analogues
US-11072642-B2 · Jul 27, 2021 · US
Natriuretic peptide receptor 1 antibodies and methods of use
US-11066469-B2 · Jul 20, 2021 · US
HANP-Fc-containing molecular conjugate
US-11008392-B2 · May 18, 2021 · US
Atrial natriuretic peptide engrafted antibodies
US-2021139555-A1 · May 13, 2021 · US
Glyco-modified atrial natriuretic peptide
US-10947289-B2 · Mar 16, 2021 · US
Natriuretic peptide receptor 1 antibodies and methods of use
US-2020392225-A1 · Dec 17, 2020 · US
Variants of C-type natriuretic peptide
US-RE48267-E · Oct 20, 2020 · US
Bnp (1-32) epitope and antibodies directed against said epitope
US-2020072853-A1 · Mar 5, 2020 · US
Antibodies recognizing generic variants
US-2019369117-A1 · Dec 5, 2019 · US
BNP (1-32) epitope and antibodies directed against said epitope
US-10495649-B2 · Dec 3, 2019 · US
MANP Analogues
US-2019352364-A1 · Nov 21, 2019 · US
Surface plasmon resonance approach to monitor protein-ligand interactions
US-10429300-B2 · Oct 1, 2019 · US
Use of c-type natriuretic peptide variants to treat osteoarthritis
US-2019247467-A1 · Aug 15, 2019 · US
Peptides with vasodilatory and/or diuretic functions
US-2019211071-A1 · Jul 11, 2019 · US
Natriuretic polypeptides
US-10344068-B2 · Jul 9, 2019 · US
Hanp-fc-containing molecular conjugate
US-2019169293-A1 · Jun 6, 2019 · US
Treating cardiovascular or renal diseases
US-2018369338-A1 · Dec 27, 2018 · US
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US-2018326019-A1 · Nov 15, 2018 · US
Treating cardiovascular or renal diseases
US-10092628-B2 · Oct 9, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/58?
- CPC C07K14/58 is the Cooperative Patent Classification code for “Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin.”
- How many patents are filed under CPC C07K14/58 (Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin)?
- Our database includes 94 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/58 growing?
- Publication counts under this code: 8 in 2024 vs 9 in 2025 (latest complete years).